New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls.
Read the Q3 2026 report
Dyadic International Inc. (DYAI) vs Jasper Therapeutics, Inc. (JSPR)
- Dyadic International Inc. DYAI 0.29 −6.45%
- Jasper Therapeutics, Inc. JSPR 8.69 −19.16%
Dyadic International Inc. and Jasper Therapeutics, Inc. are both Biotechnology companies. Dyadic International Inc. and Jasper Therapeutics, Inc. are of similar size ($12.5M and $11.9M). Across the 8 metrics below, Dyadic International Inc. leads on 4 and Jasper Therapeutics, Inc. on 4.
Valuation
Profitability
| Metric | DYAI | JSPR | Biotechnology median |
|---|---|---|---|
| Gross margin | 17.85% | — | 70.18% |
| Operating margin | (237.12%) | — | 0.00% |
| Net margin | (226.87%) | — | 0.00% |
| Free cash flow margin | (227.93%) | — | 0.00% |
| Return on equity | (47,316.89%) | 244.79% | (51.58%) |
| Return on assets | (71.43%) | (153.74%) | (45.91%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack